IOV-LUN-202: Therapeutisch

Thoracic tumors
Non-small cell lung cancer (NSCLC)
Follow-Up Treatment (Metastatic Disease)
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic NSCLC.
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic NSCLC.